Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Total 13F shares
-
14,944,988
-
Share change
-
+2,369,098
-
Total reported value
-
$341,773,287
-
Price per share
-
$22.87
-
Number of holders
-
30
-
Value change
-
+$55,049,633
-
Number of buys
-
14
-
Number of sells
-
12
Institutional Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q2 2018
As of 30 Jun 2018,
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,944,988 shares.
The largest 10 holders included
BB BIOTECH AG, RA CAPITAL MANAGEMENT, LLC, EVENTIDE ASSET MANAGEMENT, LLC, NovaQuest Capital Management, L.L.C., LORD, ABBETT & CO. LLC, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, NORGES BANK, and BlackRock Inc..
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.